JPH 14/02/2023 11:21:17 AM discloses its Preliminary Financial Statements for 2022.
| Disclosure Year | 2022 | 2021 | ||
| Disclosure Period | End of 3112 | End of 3112 | ||
| Disclosure Start Date | 01/01/2022 | 01/01/2021 | ||
| Disclosure End Date | 31/12/2022 | 31/12/2021 | ||
| Disclosure Type | Financial Disclosure | Financial Disclosure | ||
| Company's Name | JERUSALEM PHARMACEUTICALS | JERUSALEM PHARMACEUTICALS | ||
| Company Symbol | JPH | JPH | ||
| Sector | Industry Sector | Industry Sector | ||
| Currency | USD | USD | ||
| End date of legal disclosure period | 30/03/2023 | 30/03/2022 | ||
| Actual Disclosure Date | 13/02/2023 05:36:00 PM | 31/03/2022 06:44:00 PM | ||
| Hard Copy Disclosure | ||||
| Hard Copy Disclosure-English Version | ||||
| Consolidation Status | Consolidated | Consolidated | ||
| Notes Display Source | Note ID Only | Note ID Only | ||
| Preliminary or Annual? | Preliminary | Annual Report | ||
| Auditing Status | Unaudited | Audited | ||
| Net income in Cash Flow Statement | Income Before Tax | Income Before Tax | ||
| Expected date to disclose the annual report | 30/03/2023 | 30/03/2022 | ||
| Suggested date for the General Assembly meeting for the financial year | 14/04/2023 | 10/04/2022 | ||
| Where the annual report will be placed as shareholders can have access on it | الموقع الالكتروني للشركة | موقع الشركة |
The attached notes form part of these financial statements
Comments